Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1986 1
1990 1
1991 2
1992 3
1993 3
1995 2
1996 2
1998 2
1999 1
2004 1
2005 2
2006 2
2007 1
2008 2
2012 2
2016 1
2018 3
2019 2
2020 2
2021 5
2022 7
2023 3
2024 6
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.
Powles T, Valderrama BP, Gupta S, Bedke J, Kikuchi E, Hoffman-Censits J, Iyer G, Vulsteke C, Park SH, Shin SJ, Castellano D, Fornarini G, Li JR, Gümüş M, Mar N, Loriot Y, Fléchon A, Duran I, Drakaki A, Narayanan S, Yu X, Gorla S, Homet Moreno B, van der Heijden MS; EV-302 Trial Investigators. Powles T, et al. N Engl J Med. 2024 Mar 7;390(10):875-888. doi: 10.1056/NEJMoa2312117. N Engl J Med. 2024. PMID: 38446675 Clinical Trial.
Comprehensive Target Engagement by the EZH2 Inhibitor Tulmimetostat Allows for Targeting of ARID1A Mutant Cancers.
Keller PJ, Adams EJ, Wu R, Côté A, Arora S, Cantone N, Meyer R, Mertz JA, Gehling V, Cui J, Stuckey JI, Khanna A, Zhao F, Chen Z, Yu Z, Cummings RT, Taimi M, Lakhani NJ, Rasco D, Gutierrez M, Duska L, Devitt M, Rippley R, Levell J, Truong J, Wang J, Sun K, Trojer P. Keller PJ, et al. Among authors: devitt m. Cancer Res. 2024 Aug 1;84(15):2501-2517. doi: 10.1158/0008-5472.CAN-24-0398. Cancer Res. 2024. PMID: 38833522 Free PMC article. Clinical Trial.
Historical biological essentialism.
Devitt M. Devitt M. Stud Hist Philos Biol Biomed Sci. 2018 Oct;71:1-7. doi: 10.1016/j.shpsc.2018.05.004. Epub 2018 Aug 10. Stud Hist Philos Biol Biomed Sci. 2018. PMID: 30100389 No abstract available.
Risk of Major Bleeding with Ibrutinib.
Mock J, Kunk PR, Palkimas S, Sen JM, Devitt M, Horton B, Portell CA, Williams ME, Maitland H. Mock J, et al. Among authors: devitt m. Clin Lymphoma Myeloma Leuk. 2018 Nov;18(11):755-761. doi: 10.1016/j.clml.2018.07.287. Epub 2018 Aug 1. Clin Lymphoma Myeloma Leuk. 2018. PMID: 30077698
EphrinB2 Inhibition and Pembrolizumab in Metastatic Urothelial Carcinoma.
Sadeghi S, Quinn D, Dorff T, Pal S, Groshen S, Tsao-Wei D, Parikh R, Devitt M, Parikh M, Jackovich A, Ruel N, Vogelzang N, Burgess E, Siddiqi I, Gill IS, Lara PN, Dreicer R, Gill PS. Sadeghi S, et al. Among authors: devitt m. J Clin Oncol. 2023 Jan 20;41(3):640-650. doi: 10.1200/JCO.21.02923. Epub 2022 Aug 19. J Clin Oncol. 2023. PMID: 35984996 Clinical Trial.
An Unusual Renal Mass: Thinking Beyond Renal Cell Carcinoma.
Isharwal S, Ayers E, Khot R, Gupta S, Devitt M, Tandon YK. Isharwal S, et al. Among authors: devitt m. Urology. 2023 Jun;176:e5-e7. doi: 10.1016/j.urology.2023.03.006. Epub 2023 Mar 21. Urology. 2023. PMID: 36948360 No abstract available.
Adenosquamous carcinoma of the prostate with low PSMA expression.
Isharwal S, Devitt M, Gupta S, Mithqal A, Tandon YK. Isharwal S, et al. Among authors: devitt m. Int Urol Nephrol. 2023 Mar;55(3):613-615. doi: 10.1007/s11255-022-03428-6. Epub 2022 Dec 20. Int Urol Nephrol. 2023. PMID: 36538273 No abstract available.
56 results